Log in to save to my catalogue

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from o...

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from o...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90a412445b4f442b9c28c61a06a3d2a9

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

About this item

Full title

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

Publisher

England: BioMed Central Ltd

Journal title

Journal of ovarian research, 2020-05, Vol.13 (1), p.53-53, Article 53

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Central nervous system (CNS) spreading from epithelial ovarian carcinoma (EOC) is an uncommon but increasing phenomenon. We previously reported in a small series of 11 patients a correlation between Androgen Receptor (AR) loss and localization to CNS. Aims of this study were: to confirm a predictive role of AR loss in an independent validation coho...

Alternative Titles

Full title

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_90a412445b4f442b9c28c61a06a3d2a9

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_90a412445b4f442b9c28c61a06a3d2a9

Other Identifiers

ISSN

1757-2215

E-ISSN

1757-2215

DOI

10.1186/s13048-020-00655-2

How to access this item